2021
- January 11th — ISA106 – SLP therapeutic for COVID-19
- July 10th — ISA Pharmaceuticals will move to BioPartner 5
- March 27th — ISA in the news: MedNous’ article on CervISA
- March 19th — ISA Pharmaceuticals announces CervISA publication
- April 30th — A One-Two Punch for HPV-16–positive Cancers?
- December 7th — ISA Pharmaceuticals Advances Personalized Cancer Treatment
- October 15th — ISA Pharmaceuticals Establishes Advisory Board
- January 7th — ISA Pharmaceuticals Secures EUR 8 Million Funding